Documents reveal 12 top US scientists blocked from global health talks

By VirentaNews Staff — May 27, 2026

The Trump administration has systematically excluded prominent U.S. virologists and epidemiologists from international pandemic response discussions, according to internal government documents and interviews with six current and former officials. The move, which began in early 2025 and intensified in 2026, has sidelined researchers from agencies like the CDC and NIH from World Health Organization technical forums, bilateral virus surveillance talks, and global data-sharing initiatives. With new zoonotic threats emerging in Southeast Asia and Africa, the exclusion undermines global coordination, weakens trust in U.S. scientific leadership, and risks delaying early outbreak detection—potentially compromising global health security during a critical window of vulnerability.

Breakdown in U.S. Scientific Diplomacy

This exclusion marks a sharp departure from decades of U.S. leadership in global health security. Since the 2009 H1N1 pandemic, American scientists have played central roles in WHO-coordinated response networks, including the Global Outbreak Alert and Response Network (GOARN) and the Pandemic Influenza Preparedness Framework. Their expertise in genomic sequencing, vaccine development, and field epidemiology has historically been sought after in multinational crisis scenarios. However, since 2025, State Department cables and interagency emails reviewed by CNN show a deliberate policy shift: scientific participation in global health forums now requires political clearance, which has routinely been denied. Former officials say the rationale centers on “reducing foreign entanglements” and skepticism toward multilateral institutions—a stance aligned with the administration’s broader “America First” foreign policy. But experts warn that treating scientific collaboration as a political bargaining chip erodes the nonpartisan foundations of pandemic preparedness.

Who Has Been Excluded and How

At least a dozen leading U.S. researchers have been blocked from attending closed-door technical briefings on emerging pathogens, including Dr. Angela Chen of the CDC’s Emerging Infectious Diseases Division and Dr. Rajiv Malhotra from the NIH’s National Institute of Allergy and Infectious Diseases. Invitations to participate in real-time data exchanges with counterparts in Vietnam, Nigeria, and Germany were declined on their behalf by the Department of Health and Human Services (HHS), citing “pending policy review.” Emails show that even virtual participation in WHO-hosted scenario modeling workshops was restricted. In one case, a senior scientist was instructed to hand over sequencing data to a political appointee before sharing it internationally—a step without precedent in prior administrations. The freeze extends beyond individuals: the U.S. has withdrawn from the International Pathogen Surveillance Network, a G7-backed initiative launched in 2023 to standardize genomic data sharing during outbreaks.

Rising Risks to Global Health Security

The withdrawal of U.S. scientific voices coincides with a documented rise in spillover events: the number of zoonotic disease outbreaks with pandemic potential has increased 63% since 2020, according to a 2025 report by the World Health Organization. In such a high-threat environment, fragmented information flow can delay containment. Experts emphasize that early virus characterization—often conducted collaboratively across borders—is critical to vaccine design and public health messaging. The absence of U.S. researchers from these networks not only diminishes global capacity but also deprives American agencies of vital intelligence. As Dr. Linda Wong, a former WHO advisor, noted: “When we don’t share, we don’t learn. And when we don’t learn, we’re blindsided.” Internal HHS risk assessments from late 2025, leaked to CNN, rated the likelihood of a delayed U.S. response to a novel pathogen as “moderate to high” due to reduced international situational awareness.

Consequences for Research and Public Trust

The policy has far-reaching implications for both global cooperation and domestic scientific morale. International partners, including public health agencies in Canada, Japan, and the European Union, have expressed concern about the U.S. pullback, with some exploring alternative data-sharing consortia that exclude American involvement. Within the U.S., career scientists report a chilling effect: researchers are hesitant to engage in international collaborations for fear of political reprisal. This isolation also threatens long-term innovation—many breakthroughs in mRNA vaccines and antiviral therapies stemmed from pre-pandemic international research partnerships. Furthermore, public trust in health institutions may suffer if future outbreaks are perceived as being mismanaged due to political interference in science. With the 2028 election cycle approaching, the precedent sets a troubling template for how science may be subordinated to ideology during crises.

Expert Perspectives

Reactions among public health experts are sharply divided along institutional and political lines. Dr. Elena Rodriguez, a global health professor at Johns Hopkins, called the exclusions “a dereliction of duty,” arguing that “pandemics don’t respect borders, and neither should science.” In contrast, Dr. Mark Tillman, a policy advisor at the Heritage Foundation, defended the administration’s stance, saying, “Sovereign nations must control their scientific output to protect national interests.” However, even some conservative scientists express unease: “We can safeguard data without cutting off collaboration,” said Dr. Susan Park, a virologist at Brigham Young University. The debate underscores a growing tension between scientific openness and nationalist governance models.

Going forward, watchdog groups and congressional Democrats are calling for hearings on the politicization of public health. The Senate Health Committee has requested all related correspondence from HHS and the State Department. Meanwhile, global health leaders are assessing whether to formalize U.S. exclusion from future emergency coordination mechanisms. With the next major outbreak likely inevitable, the world may soon test whether fragmented, politically filtered science can keep pace with rapidly evolving pathogens.

Source: Cnn